Tools Black Friday Deals 2020: Top Early Drills, Saws, Northern Tool, Craftsman & More Savings Highlighted by Consumer Walk
Save on tools deals at the early Black Friday sale, including impact drivers, generators, toolbox,…
Save on tools deals at the early Black Friday sale, including impact drivers, generators, toolbox,…
LOS ANGELES–(BUSINESS WIRE)–$HPQ #CLASSACTION—Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law…
Willemstad, Curacao, Nov 7, 2020 – (ACN Newswire) – tether.bet, the world’s most exclusive sportsbook…
CAMBRIDGE, Mass. and TOKYO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Today, the U.S. Food and…
CEO Jeff Yapp to assume role of President TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) —…
HOPKINTON, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) — Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) (“Spring…
TORONTO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Braingrid Limited (CSE: BGRD) (“Braingrid” or the “Company”),…
SAN DIEGO, Nov. 06, 2020 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated…
SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
(Article 223-16 of General Regulation of the French financial markets authority) NEW YORK, Nov. 06,…
WORCESTER, Mass., Nov. 06, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
Summit Therapeutics Inc.(“Summit” or the “Company”) Summit Announces Closing of Private Placement of $50 Million…
MONTREAL, Nov. 06, 2020 (GLOBE NEWSWIRE) — Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a…
NOV 6 PR Complete Tauri-Gum™ Product Line (6 Flavors) The Recent Improvements to the U.S….
– Marked Reductions in Phe Observed at Two Doses – – Achieved Goal with Plans…
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of…
Bagsværd, Denmark, 6 November 2020 — This document discloses the data of the transaction(s) made…
DOYLESTOWN, Pa., Nov. 06, 2020 (GLOBE NEWSWIRE) — Kannalife, Inc. (“Kannalife” or the “Company”) (OTCQB:…
In October, SCYNEXIS submitted a New Drug Application (NDA) for ibrexafungerp for the treatment of…
100% overall response rate in dose cohort 3 and 80% overall response rate across all…